2 unchanged sentences
Our management, with the participation of our President and Chief Executive Officer and our Chief Financial Officer (our principal executive officer and principal financial and accounting officer, respectively), evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2022.
−Removed: The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.
−Removed: Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
+Added: The term “disclosure controls and procedures,”
+Added: as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.
+Added: Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
1 unchanged sentence
Internal Control Over Financial Reporting
−Removed: Management’s Annual Report on Internal Control over Financial Reporting
+Added: Management’s Annual Report on Internal Control over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) and 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP.
5 unchanged sentences
Also, projections of any evaluation of the effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures included in such controls may deteriorate.
−Removed: Our management conducted an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2021 based on the criteria described in “Internal Control-Integrated Framework” (2013) issued by the Committee of Sponsoring Organization of the Treadway Commission.
+Added: Our management conducted an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2022 based on the criteria described in “Internal Control-Integrated Framework”
+Added: (2013) issued by the Committee
+Added: of Sponsoring Organization of the Treadway Commission.
Based on this assessment, management concluded that, as of December 31, 2022, our internal control over financial reporting was effective.
5 unchanged sentences
Not applicable.
−Removed: Directors, Executive Officers and Corporate Governance.
+Added: Directors, Executive Off icers and Corporate Governance.
The information required by this Item 10 will be included in our Definitive Proxy Statement to be filed with the Securities and Exchange Commission, or SEC, with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.
−Removed: Executive Compensation.
+Added: Executiv e Compensation.
The information required by this Item 11 will be included in our Definitive Proxy Statement to be filed with the Securities and Exchange Commission, or SEC, with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.
−Removed: Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
+Added: Security Ownership of Certain Beneficial Own ers and Management and Related Stockholder Matters.
The information required by this Item 12 will be included in our Definitive Proxy Statement to be filed with the Securities and Exchange Commission, or SEC, with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.
1 unchanged sentence
The information required by this Item 13 will be included in our Definitive Proxy Statement to be filed with the Securities and Exchange Commission, or SEC, with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.
−Removed: Principal Accounting Fees and Services.
+Added: Principal Accoun ting Fees and Services.
The information required by this Item 14 will be included in our Definitive Proxy Statement to be filed with the Securities and Exchange Commission, or SEC, with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.
−Removed: Exhibits, Financial Statement Schedules.
+Added: Exhibits, Financ ial Statement Schedules.
(1) Financial Statements
4 unchanged sentences
Consolidated Statements of Comprehensive Loss
−Removed: Consolidated Statements of Stockholders’ Equity
+Added: Consolidated Statements of Stockholders’
Consolidated Statements of Cash Flows
6 unchanged sentences
001-38891) filed with the SEC on March 17, 2020)
−Removed: Amended and Restated Bylaws (incorporated by reference to Exhibit 3.4 to the Registrant’s Registration Statement on Form S-1 (File No.
−Removed: 333-230736) filed with the SEC on April 22, 2019)
−Removed: Specimen stock certificate evidencing shares of common stock (incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form S-1 (File No.
−Removed: 333-230736) filed with the SEC on April 5, 2019).
−Removed: Warrant Agreement to Purchase Preferred Stock, dated as of November 7, 2012, between the Registrant and Hercules Technology Growth Capital, Inc.
−Removed: (incorporated by reference to Exhibit 4.2 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38891) filed with the SEC on November 4, 2022)
+Added: Specimen stock certificate evidencing shares of common stock (incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019).
Warrant Agreement to Purchase Preferred Stock, dated as of September 11, 2015, between the Registrant and Hercules Technology Growth Capital, Inc.
−Removed: (incorporated by reference to Exhibit 4.3 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: (incorporated by reference to Exhibit 4.3 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
Warrant Agreement to Purchase Preferred Stock, dated as of August 4, 2016, between the Registrant and Hercules Technology Growth Capital, Inc.
−Removed: (incorporated by reference to Exhibit 4.4 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: (incorporated by reference to Exhibit 4.4 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
2 unchanged sentences
Ninth Amended and Restated Investor Rights Agreement, dated as of May 6, 2019, by and among TransMedics Group, Inc., TransMedics, Inc.
−Removed: and the shareholders party thereto (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: and the shareholders party thereto (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
001-38891) filed with the SEC on May 1, 2019)
−Removed: Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (incorporated by reference to Exhibit 10.2 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (incorporated by reference to Exhibit 10.2 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Amended and Restated 2004 Stock Incentive Plan (incorporated by reference to Exhibit 10.3 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Amended and Restated 2004 Stock Incentive Plan (incorporated by reference to Exhibit 10.3 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Form of Incentive Stock Option Agreement under 2004 Stock Incentive Plan (incorporated by reference to Exhibit 10.4 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Form of Incentive Stock Option Agreement under 2004 Stock Incentive Plan (incorporated by reference to Exhibit 10.4 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Amended and Restated 2014 Stock Incentive Plan (incorporated by reference to Exhibit 10.5 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Amended and Restated 2014 Stock Incentive Plan (incorporated by reference to Exhibit 10.5 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Form of Incentive Stock Option Agreement under 2014 Stock Incentive Plan (incorporated by reference to Exhibit 10.6 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Form of Incentive Stock Option Agreement under 2014 Stock Incentive Plan (incorporated by reference to Exhibit 10.6 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Form of Non-Qualified Stock Option Agreement under 2014 Stock Incentive Plan (incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Form of Non-Qualified Stock Option Agreement under 2014 Stock Incentive Plan (incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Form of Restricted Stock Agreement under 2014 Stock Incentive Plan (incorporated by reference to Exhibit 10.8 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Form of Restricted Stock Agreement under 2014 Stock Incentive Plan (incorporated by reference to Exhibit 10.8 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: 2019 Stock Incentive Plan (incorporated by reference to Exhibit 10.9 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: 2019 Stock Incentive Plan (incorporated by reference to Exhibit 10.9 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 22, 2019)
−Removed: Form of Incentive Stock Option Agreement under 2019 Stock Incentive Plan (incorporated by reference to Exhibit 10.10 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Form of Incentive Stock Option Agreement under 2019 Stock Incentive Plan (incorporated by reference to Exhibit 10.10 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 22, 2019)
−Removed: Form of Non-Statutory Stock Option Agreement under 2019 Stock Incentive Plan (incorporated by reference to Exhibit 10.11 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Form of Non-Statutory Stock Option Agreement under 2019 Stock Incentive Plan (incorporated by reference to Exhibit 10.11 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 22, 2019)
−Removed: 2019 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.12 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: 2019 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.12 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 22, 2019)
−Removed: 2019 Cash Incentive Plan (incorporated by reference to Exhibit 10.13 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: 2019 Cash Incentive Plan (incorporated by reference to Exhibit 10.13 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 22, 2019)
TransMedics Group, Inc.
−Removed: Inducement Plan (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: Inducement Plan (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
001-38891) filed with the SEC on August 9, 2021)
1 unchanged sentence
Hassanein, M.D.
−Removed: (incorporated by reference to Exhibit 10.14 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: (incorporated by reference to Exhibit 10.14 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
Executive Retention Agreement, dated as of November 15, 2007, by and among the Registrant and Tamer I.
−Removed: (incorporated by reference to Exhibit 10.15 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: (incorporated by reference to Exhibit 10.15 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Executive Retention Agreement, dated as of March 23, 2015, by and among the Registrant and Stephen Gordon (incorporated by reference to Exhibit 10.16 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Executive Retention Agreement, dated as of March 23, 2015, by and among the Registrant and Stephen Gordon (incorporated by reference to Exhibit 10.16 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Lease Agreement, dated as of June 25, 2004, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.17 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Lease Agreement, dated as of June 25, 2004, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.17 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: First Amendment to Lease, dated as of September 28, 2004, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.18 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: First Amendment to Lease, dated as of September 28, 2004, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.18 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Second Amendment to Lease, dated as of November 29, 2005, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.19 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Second Amendment to Lease, dated as of November 29, 2005, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.19 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Third Amendment to Lease, dated as of June 12, 2006, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.20 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Third Amendment to Lease, dated as of June 12, 2006, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.20 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Fourth Amendment to Lease, dated as of February 1, 2007, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.21 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Fourth Amendment to Lease, dated as of February 1, 2007, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.21 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Fifth Amendment to Lease, dated as of April 30, 2010, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.22 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Fifth Amendment to Lease, dated as of April 30, 2010, between the Registrant and 200 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.22 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Lease Agreement, dated as of June 25, 2004, between the Registrant and 30 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.23 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Lease Agreement, dated as of June 25, 2004, between the Registrant and 30 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.23 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Second Amendment to Lease, dated as of November 29, 2005, between the Registrant and 30 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.24 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Second Amendment to Lease, dated as of November 29, 2005, between the Registrant and 30 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.24 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Third Amendment to Lease, dated as of April 30, 2010, between the Registrant and 30 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.25 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Third Amendment to Lease, dated as of April 30, 2010, between the Registrant and 30 Minuteman Limited Partnership (incorporated by reference to Exhibit 10.25 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
1 unchanged sentence
001-38891) filed with the SEC on March 17, 2020)
−Removed: Credit Agreement, dated as of June 22, 2018, by and between the Registrant and OrbiMed Royalty Opportunities II, LP (incorporated by reference to Exhibit 10.26 to the Registrant’s Registration Statement on Form S-1 (File No.
−Removed: 333-230736) filed with the SEC on April 5, 2019)
−Removed: Pledge and Security Agreement, dated as of June 22, 2018, by and between the Registrant and OrbiMed Royalty Opportunities II, LP (incorporated by reference to Exhibit 10.27 to the Registrant’s Registration Statement on Form S-1 (File No.
−Removed: 333-230736) filed with the SEC on April 5, 2019)
−Removed: Guarantee, dated as of June 22, 2018, made by TransMedics B.V.
−Removed: in favor of OrbiMed Royalty Opportunities II, LP (incorporated by reference to Exhibit 10.28 to the Registrant’s Registration Statement on Form S-1 (File No.
−Removed: 333-230736) filed with the SEC on April 5, 2019)
−Removed: Supplement to Guarantee, dated as of May 6, 2019, by TransMedics Group, Inc.
−Removed: in favor of OrbiMed Royalty Opportunities II, LP.
−Removed: (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-38891) filed with the SEC on May 1, 2019)
−Removed: Supplement to Pledge and Security Agreement, dated as of May 6, 2019, by TransMedics Group, Inc.
−Removed: in favor of OrbiMed Royalty Opportunities II, LP.
−Removed: (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-38891) filed with the SEC on May 1, 2019)
−Removed: Third Waiver to Credit Agreement, dated as of March 29, 2019, by and among TransMedics, Inc., TransMedics B.V.
−Removed: and Orbimed Royalty Opportunities II, LP (incorporated by reference to Exhibit 10.35 to the Registrant’s Registration Statement on Form S-1 (File No.
−Removed: 333-230736) filed with the SEC on April 22, 2019)
−Removed: License Agreement dated as of August 27, 2002 by and between the Registrant and The Department of Veterans Affairs (incorporated by reference to Exhibit 10.31 to the Registrant’s Registration Statement on Form S-1 (File No.
−Removed: 333-230736) filed with the SEC on April 5, 2019)
−Removed: Development and Supply Agreement dated as of May 24, 2005 by and between the Registrant and Fresenius Kabi AB (incorporated by reference to Exhibit 10.32 to the Registrant’s Registration Statement on Form S-1 (File No.
−Removed: 333-230736) filed with the SEC on April 5, 2019)
−Removed: Contract Manufacturing Agreement dated as of April 1, 2015 by and between the Registrant and Fresenius Kabi Austria GmbH (incorporated by reference to Exhibit 10.33 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Credit Agreement, dated as of July 25, 2022, by and among TransMedics Group, Inc., the lenders party thereto and Canadian Imperial Bank of Commerce, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38891) filed with the SEC on July 29, 2022)
+Added: Guarantee and Collateral Agreement, dated as of July 25, 2022, by and among TransMedics Group, Inc., TransMedics, Inc., TransMedics B.V.
+Added: and Canadian Imperial Bank of Commerce (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38891) filed with the SEC on July 29, 2022)
+Added: Development and Supply Agreement dated as of May 24, 2005 by and between the Registrant and Fresenius Kabi AB (incorporated by reference to Exhibit 10.32 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
−Removed: Board Observer Agreement dated as of April 5, 2019 by and among the Registrant, Abrams Capital Partners I, L.P., Abrams Capital Partners II, L.P., Grant Hollow International, L.P., Riva Capital Partners III, L.P.
−Removed: and Whitecrest Partners, LP (incorporated by reference to Exhibit 10.34 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: Contract Manufacturing Agreement dated as of April 1, 2015 by and between the Registrant and Fresenius Kabi Austria GmbH (incorporated by reference to Exhibit 10.33 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019)
Amendment to Executive Retention Agreement, be and between TransMedics, Inc.
−Removed: and Stephen Gordon, dated April 10, 2020 (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-38891) filed with the SEC on April 13, 2020).
−Removed: Promissory Note, dated April 20, 2020 ((incorporated by reference to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-38891) filed with the SEC on April 24, 2020).
−Removed: Second Amendment to Credit Agreement, dated as of April 23, 2020, by and among TransMedics, Inc., TransMedics Croup, Inc., TransMedics, B.V.
−Removed: and Orbimed Royalty Opportunities II, L.P.
−Removed: (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No.
+Added: and Stephen Gordon, dated April 10, 2020 (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No.
001-38891) filed with the SEC on April 13, 2020).
−Removed: Omnibus Amendment #2 to Lease, dated as of June 1, 2020, by and among the Company and Whetstone 200 Minuteman Park, LLC and Whetstone 30 Minuteman Park, LLC (incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: Omnibus Amendment #2 to Lease, dated as of June 1, 2020, by and among the Company and Whetstone 200 Minuteman Park, LLC and Whetstone 30 Minuteman Park, LLC (incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q (File No.
001-38891) filed with the SEC on August 7, 2020).
−Removed: List of Subsidiaries (incorporated by reference to Exhibit 21.1 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: List of Subsidiaries (incorporated by reference to Exhibit 21.1 to the Registrant’s Registration Statement on Form S-1 (File No.
333-230736) filed with the SEC on April 5, 2019).
6 unchanged sentences
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
+Added: Inline XBRL Instance Document –
+Added: the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
Inline XBRL Taxonomy Extension Schema Document
5 unchanged sentences
* Filed herewith.
+Added: ** Furnished herewith.
# Indicated a management or compensatory plan, contract or arrangement.
2 unchanged sentences
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized .
−Removed: March 1, 2022
+Added: February 27, 2023
/s/ Stephen Gordon
5 unchanged sentences
President, Chief Executive Officer, Director
−Removed: March 1, 2022
+Added: February 27, 2023
/s/ Stephen Gordon
Chief Financial Officer, Treasurer and Secretary
−Removed: March 1, 2022
+Added: February 27, 2023
Stephen Gordon
Chairman of the Board of Directors
−Removed: March 1, 2022
+Added: February 27, 2023
/s/ Edward M.
−Removed: March 1, 2022
+Added: February 27, 2023
/s/ Thomas J.
−Removed: March 1, 2022
−Removed: March 1, 2022
+Added: February 27, 2023
+Added: February 27, 2023
/s/ David Weill, M.D.
−Removed: March 1, 2022
+Added: February 27, 2023
David Weill, M.D.
/s/ Merilee Raines
−Removed: March 1, 2022
+Added: February 27, 2023
Merilee Raines
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.